Literature DB >> 25811420

Cyclooxygenase as a target in chemoprevention by probiotics during 1,2-dimethylhydrazine induced colon carcinogenesis in rats.

Sohini Walia1, Rozy Kamal, Sarbjit Singh Kanwar, Davinder Kumar Dhawan.   

Abstract

The present study was undertaken to assess the effects of potential probiotics in regulating the activity of cyclooxygenase-2 (COX-2) along with other morphological and histological analysis during 1,2-dimethylhydrazine (DMH) induced colon carcinogenesis in rats. The rats were divided into 6 groups viz., normal control, Lactobacillus plantarum (AdF10) treated, Lactobacillus rhamnosus GG (LGG) treated, DMH treated, AdF10 + DMH treated and LGG + DMH treated. Probiotics were supplemented to rats at dose levels of 2 × 10(10) cells per day for 6 days in a week. All the treatments were continued for a period of 16 wk. DMH treatment resulted in a statistically significant increase in the levels of total sialic acid (TSA). However, on supplementation with probiotics, a significant reduction in TSA was observed. DMH treatment brought about a significant increase in the expression of COX-2. But, supplementation of probiotics brought down the protein expression to moderate level. Further, supplementation with probiotics was also able to reduce tumor incidence, tumor multiplicity and average tumor size. Therefore, treatment with probiotics has the potential of providing protection against colon cancer by suppressing the COX-2 expression as one of the protective mechanisms.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25811420     DOI: 10.1080/01635581.2015.1011788

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  7 in total

1.  Chemoprevention by Probiotics During 1,2-Dimethylhydrazine-Induced Colon Carcinogenesis in Rats.

Authors:  Sohini Walia; Rozy Kamal; D K Dhawan; S S Kanwar
Journal:  Dig Dis Sci       Date:  2018-02-09       Impact factor: 3.199

2.  Adherence potential of indigenous lactic acid bacterial isolates obtained from fermented foods of Western Himalayas to intestinal epithelial Caco-2 and HT-29 cell lines.

Authors:  Sakshi Sharma; Sarbjit Singh Kanwar
Journal:  J Food Sci Technol       Date:  2017-08-28       Impact factor: 2.701

3.  Effects of Probiotics at the Interface of Metabolism and Immunity to Prevent Colorectal Cancer-Associated Gut Inflammation: A Systematic Network and Meta-Analysis With Molecular Docking Studies.

Authors:  Sinjini Patra; Nilanjan Sahu; Shivam Saxena; Biswaranjan Pradhan; Saroj Kumar Nayak; Anasuya Roychowdhury
Journal:  Front Microbiol       Date:  2022-05-27       Impact factor: 6.064

4.  Structural Change in Microbiota by a Probiotic Cocktail Enhances the Gut Barrier and Reduces Cancer via TLR2 Signaling in a Rat Model of Colon Cancer.

Authors:  Eugene Dogkotenge Kuugbee; Xueqi Shang; Yaser Gamallat; Djibril Bamba; Annoor Awadasseid; Mohammed Ahmed Suliman; Shizhu Zang; Yufang Ma; Gift Chiwala; Yi Xin; Dong Shang
Journal:  Dig Dis Sci       Date:  2016-07-06       Impact factor: 3.199

5.  Functional Changes in the Gut Microbiome Contribute to Transforming Growth Factor β-Deficient Colon Cancer.

Authors:  Scott G Daniel; Corbie L Ball; David G Besselsen; Tom Doetschman; Bonnie L Hurwitz
Journal:  mSystems       Date:  2017-09-26       Impact factor: 6.496

6.  Preventive and Tumor-Suppressive Effects of Lactobacillus Paracasei X12 in Rat Model of Colorectal Cancer.

Authors:  Sayyid Ali Mousavi Jam; Mohammad Morshedi; Ahmad Yari Khosroushahi; Amir Taher Eftekharsadat; Maedeh Alipour; Beitullah Alipour
Journal:  Iran J Pharm Res       Date:  2020       Impact factor: 1.696

Review 7.  An Update on the Effects of Probiotics on Gastrointestinal Cancers.

Authors:  Amirhossein Davoodvandi; Farzaneh Fallahi; Omid Reza Tamtaji; Vida Tajiknia; Zarrin Banikazemi; Hadis Fathizadeh; Mohammad Abbasi-Kolli; Michael Aschner; Maryam Ghandali; Amirhossein Sahebkar; Mohsen Taghizadeh; Hamed Mirzaei
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.